Skip to main content

Vyndaqel Prices, Coupons and Patient Assistance Programs

Vyndaqel (tafamidis) is a member of the transthyretin stabilizers drug class and is commonly used for Amyloid Cardiomyopathy, and Transthyretin-Related Amyloidosis.

The cost for Vyndaqel oral capsule meglumine 20 mg is around $23,525 for a supply of 120 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Vyndaqel is available as a brand name drug only, a generic version is not yet available. View generic Vyndaqel availability for more details.

Vyndaqel prices

Oral Capsule

Quantity Per unit Price
120 $196.05 $23,525.40

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Vyndaqel Coupons, Copay Cards and Rebates

Vyndaqel offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Vyndaqel Co-Pay Savings Program

Eligible commercially insured patients may pay as little as $0 per monthly prescription with savings of up to $60,000 per calendar year; for additional information contact the program at 888-222-8475.

Applies to:
Vyndaqel
Number of uses:
per prescription per calendar year
Expires
December 31, 2024

Form more information phone: 888-222-8475 or Visit website

Patient Assistance & Copay Programs for Vyndaqel

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 866-316-7263 Visit Website

Provider: VyndaLink Program

Eligibility requirements:
  1. Contact program for details.
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US or Puerto Rico
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details. Please visit: (www.Vyndaqel.com) (www.Vyndamax.com) for more information.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 888-222-8475 Visit Website

Provider: Pfizer RxPathways

Eligibility requirements:
  1. Contact program for details.
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, and patient assistance programs are available for eligible patients. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Vyndaqel (tafamidis meglumine) Capsule

More information please phone: 844-989-7284 Visit Website